Citurgia Biochemicals Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Citurgia Biochemicals CMP Rs.116. Market cap Rs.1,553 Cr. PE Not meaningful. 12-month target Rs.118-133.

Updated: 8 Jul 2026 • 11:41 am

Posted by:

Citurgia Biochemicals Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Citurgia Biochemicals Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Citurgia Biochemicals shares trading at Rs.116 against a market capitalisation of Rs.1,553 Cr and a price-to-earnings multiple of Not meaningful. As a specialty chemicals name on the NSE and BSE, Citurgia Biochemicals enters the Citurgia Biochemicals Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.

Quarterly financials for Citurgia Biochemicals are not yet fully available on Univest's data partners for this cycle; investors should track Screener.in and the NSE/BSE filings directly for the Citurgia Biochemicals Q1 Results FY27 result date and cross-check any figures before making investment decisions.

Get Free Investment Predictions and Citurgia Biochemicals Research at Univest

Citurgia Biochemicals (NSE: CITURGIBIO) operates in the specialty chemicals space and is tracked on Univest under its NSE and BSE listings ahead of the Citurgia Biochemicals Q1 Results FY27 season, forming the base against which the Citurgia Biochemicals Q1 Results FY27 estimates in this article are built. This Citurgia Biochemicals Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company's own disclosures.

Table of Contents

Citurgia Biochemicals Q1 FY27 Estimates

Metric	Detail
CMP	Rs.116
Market Cap	Rs.1,553 Cr
Results Date	July-August 2026 (indicative)
12-Month Target (Uniresearch Estimate)	Rs.118-133

Univest, a SEBI-Registered Investment Advisor, Tracks Citurgia Biochemicals Ahead of Q1 FY27 Results

Key Catalysts to Watch

1. Realisation Stabilisation

Stabilising realisations after recent price volatility in key product segments is one of the primary variables that analysts are tracking ahead of Citurgia Biochemicals's Q1 FY27 results and FY27 guidance. The market's reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Citurgia Biochemicals share price target or faces renewed pressure.

2. Volume Growth

Volume growth from capacity utilisation improvement across manufacturing units is one of the primary variables that analysts are tracking ahead of Citurgia Biochemicals's Q1 FY27 results and FY27 guidance. The market's reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Citurgia Biochemicals share price target or faces renewed pressure.

3. Export Demand

Export demand recovery supporting topline in key specialty chemical categories is one of the primary variables that analysts are tracking ahead of Citurgia Biochemicals's Q1 FY27 results and FY27 guidance. The market's reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Citurgia Biochemicals share price target or faces renewed pressure.

Download the Univest iOS App or Univest Android App to track Citurgia Biochemicals's live price and Q1 FY27 result updates.

Key Risks to the Citurgia Biochemicals Q1 Results FY27 Outlook

Realisation volatility from global oversupply or demand softness.
Input cost pressure from crude-linked or key raw material price swings.
Regulatory or environmental compliance costs affecting margins.

Recent Performance Context

Detailed recent-quarter financials for Citurgia Biochemicals were not available from Univest's data partners at the time of writing. Investors should check Screener.in or the company's exchange filings for the latest verified numbers before the Q1 FY27 results.

Technical Analysis Ahead of Citurgia Biochemicals Q1 Results FY27

Citurgia Biochemicals shares last traded at Rs.116. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.

Share Price Target Based on the Citurgia Biochemicals Q1 Results FY27 Outlook

3-6 Month Target

Over a 3-6 month horizon, the Citurgia Biochemicals Q1 Results FY27 trailing-growth framework points to a range of Rs.114-124 for Citurgia Biochemicals, contingent on the Citurgia Biochemicals Q1 Results FY27 print matching or beating the trailing growth trend.

12-Month Target

The 12-month target (Uniresearch estimate) tied to this Citurgia Biochemicals Q1 Results FY27 view for Citurgia Biochemicals works out to Rs.118-133, built on the same trailing revenue growth trend and current valuation multiple. Tracking is how Univest research categorises the stock heading into Citurgia Biochemicals Q1 Results FY27, not a formal Buy or Sell call.

FY27-28 Outlook

Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Citurgia Biochemicals Q1 Results FY27 analysis would put Citurgia Biochemicals in a Rs.124-145 range, though this is sensitive to sector-wide demand, cost trends and any change in the company's competitive position.

What to Watch in the Citurgia Biochemicals Q1 Results FY27 Print

Revenue and PAT versus the Citurgia Biochemicals Q1 Results FY27 estimate range in this preview.
Management commentary on FY27 growth guidance and margin trajectory relevant to the Citurgia Biochemicals Q1 Results FY27 narrative.
Stabilising realisations after recent price volatility in key product segments
Realisation volatility from global oversupply or demand softness

Conclusion on Citurgia Biochemicals Q1 Results FY27

Citurgia Biochemicals enters the Q1 FY27 results season trading at Rs.116, with the 12-month Uniresearch target range of Rs.118-133 reflecting a tracking stance. Investors tracking the Citurgia Biochemicals Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Citurgia Biochemicals Q1 Results FY27

When are Citurgia Biochemicals Q1 FY27 results expected?

Ans. Citurgia Biochemicals's Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.

What is the Citurgia Biochemicals Q1 FY27 revenue estimate?

Ans. Detailed quarterly estimates are not available for Citurgia Biochemicals at this time; check Screener.in or the company's exchange filings for verified numbers.

What is the Citurgia Biochemicals share price target?

Ans. The 12-month Uniresearch estimate for Citurgia Biochemicals share price target is Rs.118-133, based on trailing growth and current valuation multiples.

Is Citurgia Biochemicals a good buy before Q1 FY27 results?

Ans. Citurgia Biochemicals is tracking heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.

What should investors watch in Citurgia Biochemicals's Q1 FY27 results?

Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and stabilising realisations after recent price volatility in key product segments.